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An increasing prevalence of HIV-1 non-B variants is being noticed in several European
regions, particularly in countries such as Portugal, which have closer contacts with
African endemic areas, where multiple HIV subtypes cocirculate. HIV-1 subtyping by
phylogenetic analyses of reverse transcriptase, protease and env (C2–V3) genomic regions
was carried out in plasma collected from 18 HIV-1-infected subjects living in Coimbra,
Portugal, and suspected to be infected with non-B variants. Three (16.7%) subjects carried
recombinant B/G viruses (BV3/BRT/Gpro; GV3/URT/Bpro; AV3/GRT/Bpro), whereas all the
remaining individuals were infected with HIV-1 subtype B. This is the first report of
recombinant B/G subtypes in Portugal.
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HIV-1 can be divided into three distinct and highly
divergent groups: M (major), O (outlier), and N
(new). There are at least 21 major genetic forms
within HIV-1 group M, including nine subtypes
(A, B, C, D, F, G, H, J, K) and 12 major circulating
recombinant forms [1–4]. Classification of HIV into
subtypes is based primarily on the analysis of
genetic sequences coding for the envelope (env)
and other structural (gag, pol) proteins [1]. Subtype
B circulates throughout the world, and is predo-
minant in North America and Europe. However,
non-B subtypes have been recently noticed in
different European countries [5–8], and are widely
present in Africa [1,9]. The proportion of HIV-1
subtypes and its distribution is not uniform in
Sub-Saharan African regions [9–11], where a large
variety of recombinant forms is circulating [2,9].
Knowledge of the circulating HIV genetic sub-
types in a community may have important impli-
cations for diagnosis. For instance, the sensitivity
of some serologic tests may be compromised [12],
as well as the performance of nucleic acid testing
[13–15], including viral load assays [16,17]. Less
probably, HIV transmission and disease progres-
sion may be subtype dependent [18,19].
An extensive relationship between Portugal and
distant regions in other continents has existed for
many centuries, especially with the former Portu-
guese territories situated in west (Guinea-Bissau),
central (Angola) and south (Mozambique) Sub-
Saharan regions of Africa, as well as in South
America (Brazil). Travel for tourism or business
reasons to these areas continues to be common for
the Portuguese population. The objective of this
work was to seek the presence of HIV-1 non-B
subtypes in Coimbra, Portugal. To our knowledge,
this is the first study evaluating this issue in our
country.
We selected a group of 18 HIV-infected subjects,
probably infected overseas and undergoing regu-
lar follow-up in one outpatient clinic located in
Coimbra. Thirteen (72%) were males. Eleven (61%)
had acquired HIV-1 infection in Sub-Saharan
Africa, four in western Europe, and three in South
America. Ten (55%) subjects were born in Portu-
gal, and the rest were foreigners, mostly coming
from countries with Portuguese as the official
language (Brazil, Mozambique, Angola, and Gui-
nea-Bissau), where non-B subtypes are circulating
[1,9]. Their main epidemiologic and clinical data
are given in Tables 1 and 2, respectively.
The diagnosis of HIV infection in these patients
was made between 1987 and 1999 by ELISA, and
was confirmed by Western blot. Quantification of
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HIV-1 RNA in plasma was performed with the
Amplicor HIV-1 Monitor test, version 1.5 (Roche
Diagnostics, Lisbon, Portugal). All patients were
classified according to the Centers for Disease
Control (CDC) criteria. The CD4þ lymphocyte
count was measured by flow cytometry. Samples
were taken during September 1998 and April 1999.
HIV-1 RNA was extracted from 500 mL of each
plasma specimen. A 297-bp nested PCR of the
protease gene was performed, under conditions
previously described [20]. The analysis of a 550-
bp region within the RT gene and of a 318-bp
fragment within the env gene covering the V3
region was done as previously reported [21].
Table 1 Main epidemiologic features of the study population
Patient
Age
(years) Gender
Country of
birth
Country of
infection
Route of
infection
Year of
diagnosis Subtype
GenBank
accession
number
P2 43 M Guinea-Bissau Guinea-Bissau Htsex 1998 B –
P4 58 M Portugal Tanzania Htsex 1999 B AF204117
P5 54 M Portugal Rwanda Htsex 1991 B AF204118
P6 26 F New Zealand Germany Htsex 1996 B AF204119
P8 40 M Portugal Italy IDU 1987 B AF204121
P9 55 M Guinea-Bissau Guinea-Bissau Htsex 1999 B AF204122
P10 29 F Brazil Brazil IDU 1993 B AF204123
P12 52 M Portugal Angola Htsex 1996 B AF204125
P13 38 M Portugal Zaire Htsex 1997 B AF204126
P18 56 M Portugal Namibia Htsex 1999 B AF204131
P19 60 M Mozambique Mozambique Htsex 1998 B AF204132
P21 30 F Italy Italy IDU 1998 B AF204134
P23 41 M Mozambique Mozambique Htsex 1998 B AF204136
P24 36 F Portugal Switzerland IDU 1987 B AF204137
P25 31 F Angola Angola Htsex 1997 B AF204138
P28 28 M Portugal Cuba Htsex 1997 B AF204141
P29 38 M Portugal Zaire Htsex 1998 G AF204142
P31 30 M Portugal New Zealand Htsex 1996 B AF204144
F, female; M, male; Htsex, heterosexual; IDU, intravenous drug user.
Table 2 Main clinical features of the study population
Patient
CD4þ lymphocyte
count (cells/mm3)
Viral load
(HIV RNA copies/mL)
Antiretroviral
therapy
CDC
category
Reason for
HIV testing
P2 264 24 612 D4Tþ 3TCþ IDV B.2 Routine screening
P4 18 206 000 AZTþ 3TCþNFV C3 Pneumocystis carinii pneumonia
P5 352 370 086 d4TþddlþNFV C3 Herpes zoster ophtalmicus
P6 242 80 481 d4Tþ 3TCþ IDV A3 HIV-positive partner
P8 528 <400 d4Tþ 3TCþNFV C3 Routine screening
P9 48 703 000 Naive C3 Herpes zoster ophtalmicus
P10 154 245 000 Naive B3 Pregnancy screening
P12 513 1997 AZTþ 3TCþ IDV A2 Acute viral syndrome
P13 88 <400 AZTþ 3TCþ IDV C3 Kaposi’s sarcoma
P18 1224 953 d4Tþ 3TCþNVP A1 Acute viral syndrome
P19 312 <400 AZTþ 3TCþNFV C3 Fever of unknown origin
P21 465 8070 Naive A2 Routine screening
P23 330 14 000 Naive A2 Routine screening
P24 78 150 689 AZTþ 3TCþNFV C3 Routine screening
P25 135 <400 d4Tþ 3TCþ SQV A3 Pregnancy screening
P28 648 1140 Naive A2 Routine screening
P29 114 10 051 AZTþ 3TCþNFV A3 Routine screening
P31 15 86 613 d4Tþ 3TCþ IDV C3 HSV chronic genital ulcers
ZDV, zidovudine; ddI, didanosine; 3TC, lamivudine; d4T, stavudine; NVP, nevirapine; RTV, ritonavir; IDV, indinavir;
SQV, saquinavir; NFV, nelfinavir.
Concise Communication 423
 2003 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 9, 422–425
Characterization of HIV-1 subtypes was carried
out by direct automatic sequencing of the nested
PCR fragments on an ABI PRISM 310 Genetic
Analyzer (Applied Biosystems, Foster City, CA,
USA). Twelve HIV-1 reference sequences belong-
ing to HIV-1 groups M and N isolates, having
full-length genomes available at GenBank, were
selected for comparative analysis to produce a
phylogenetic tree. The tree topology was obtained
using the neighbor-joining program, and con-
firmed with PUZZLE, a maximum likelihood
method. Pairwise distance matrices were esti-
mated with the Kimura two-parameter model
with the DNADIST program, as implemented in
the PHYLIP package. Bootstrap re-sampling (1000
data sets) of the multiple alignment was per-
formed to test the statistical robustness of the tree.
Genetic subtyping in the protease gene was per-
formed in all 18 samples processed and amplified
on different days. Surprisingly, HIV-1 subtype B
was the predominant variant (94.4%). Only one
sample (P29) showed a protease sequence cluster-
ing within clade G. The phylogenetic tree in Figure
1 shows only HIV-1 subtypes A, B, C and G as
reference strains, taken as a root one isolate of HIV-
1 group N. Additional phylogenetic trees includ-
ing all HIV-1 subtypes (A–H) were constructed,
and confirmed these results (data not shown).
Patient 29 was born in Portugal, but was infected
while living in Zaire. Additional genetic sequence
analyses of other genomic regions (env and RT)
showed a discrepant topology, clustering within
subtype B (Table 3), suggesting that this individual
carried a recombinant G/B virus.
The finding of this recombinant virus suggested
the possibility that others could also exist. To con-
firm this hypothesis, we selected those individuals
most probably infected in Africa, where most
recombinant forms circulate [1,2,9]. Genetic sequ-
ence analyses of the env and RT regions were per-
formed. Again, a discrepant topology was found
in another two samples, P2 and P12 (Table 3). The
RT region of P12 could not be amplified, and
therefore could not be assigned to a specific sub-
type. Patient 2 was most probably infected in
Guinea-Bissau, and patient 12 in Angola.
The purpose of this study was to look for the
presence of HIV-1 non-B subtypes in Coimbra,
Portugal. Our findings confirm that B/G recombi-
nants are currently circulating and represent the
greater proportion of non-B subtypes, being found
in all instances among subjects infected overseas.
HIV-1 non-B subtypes and recombinant forms
have been previously reported in Spain, our neigh-
boring country [8,21]. Interestingly, subtype G
recombinants are the most frequent non-B variants
in Spain, where two different clade G variants
seem to split epidemiologically. Whereas A/G
recombinants predominate among African immi-
grants [22], B/G recombinants represent the most
common non-B variant among natives (mainly
Figure 1 Phylogenetic tree of the HIV-1 protease-coding
region in 18 subjects living in Coimbra, Portugal (in bold).
Table 3 Recombinant nature of viruses in three patients
Patient Protease RT Envelope
P2 B G A
P12 B NA G
P29 G B B
NA, not amplified genetic material.
 2003 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 9, 422–425
424 Clinical Microbiology and Infection, Volume 9 Number 5, May 2003
drug users) in some regions such as Galicia [22,23],
which is on the Portuguese border. A link between
our Portuguese B/G viruses and those found in
Galicia is unlikely, considering the large genetic
distance reported between virus isolates.
Although HIV-1 non-B subtypes may currently
be uncommon in Coimbra, the future public-
health impact of their presence is unclear, as is
their existence in other Portuguese regions. In the
best case, these variants and their recombinants
may be confined to their hosts, but further dis-
semination of these minority HIV-1 variants needs
to be investigated. There is growing concern that
some HIV-1 subtypes might be less susceptible to
antiretroviral drugs, as has been suggested for
subtype D [24] and for subtype G [25].
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